Publication: Effect of Hepatosteatosis on the Virological Response in Entecavir and Tenofovir Therapies
Program
Authors
KORKMAZ, PINAR
Demirturk, Nese
Batirel, Ayse
Tulek, Necla
Ozguler, Muge
Harman, Rezan
Cinar, Gule
TOKA, ONUR
Yoruk, Gulsen
Ataman-Hatipoglu, Cigdem
Advisor
Language
Type
Publisher
Journal Title
Journal ISSN
Volume Title
Abstract
Objective: Both chronic hepatitis B (CHB) and hepatosteatosis may lead to necroinflammation in liver. Therefore, the presence of hepatosteatosis might negatively affect the efficacy of antiviral therapy. We aimed to determine the effect of hepatosteatosis on virological response in patients with CHB receiving entecavir (ETV) and tenofovir (TDF) treatment.
Description
Source:
Keywords:
Keywords
Citation
KORKMAZ P., Demirturk N., Batirel A., Tulek N., Ozguler M., Harman R., Cinar G., TOKA O., Yoruk G., Ataman-Hatipoglu C., et al., -Effect of Hepatosteatosis on the Virological Response in Entecavir and Tenofovir Therapies-, KLIMIK JOURNAL, cilt.32, ss.265-274, 2019